The Akdital Group, the leading private health operator in Morocco, recorded 2024 highlight indicators, a year that was characterized by the continuation of clinical openings in the field. The turnover reached 2.95 billion DH, a 55% jump in the annual layer. ” This dynamic of evolution reflects both the rise of facilities that have been open in the past two years, as well as continuous progression of historical structures. With regard to the activities, oncology continues its strong growth and strengthens its contribution to sales »explains the group.
The earlier exercise also made it possible to improve profitability, everything with cost control. The EBITDA is therefore 64%compared to the previous year, in particular from continuous improvement in operational efficiency. The EBITDA Margin rate thus continues its growth from 26.8% in 2023 to 28.4% in 2024. The consolidated net profit was 348 million ie, which increased net rise by 76%. In this context, the group publishes an RNPG of 315 million DH and intends to distribute a dividend of 10/actions.
“Akdital signs an extraordinary new year, which is characterized by strong development dynamics and a solid operating performance, which confirms the relevance of its strategic decisions. We have accepted a major challenge this year by opening all 12 planned facilities within the announced deadlines, whereby our obligations for our patients and partners are respected »» Rochdi Talbi, CEO of the group, is happy. ” The successful capital increase in 2024 offers us the opportunity to accelerate our expansion and to support our determination to ensure access to all Moroccans of high -quality health care. “he adds.
In 2024, Akdital continued his investment efforts by injecting 1.79 billion DH (+64% compared to 2023) into the equipment of new facilities and at future locations. On December 31, 2024, net debt was 1.75 billion DH, a ratio of 2.0 compared to EBITDA around 2.4 in the previous year, which is due to a strong strict management of the growth of the group.
